Digitalising Drug Discovery

Senior Industry Leaders Will Share Their Insights
This webinar discussion, hosted by the Financial Times and BIOVIA, Dassault Systèmes, will explore how adapting AI and ML can revolutionise early stage drug development. There will also be discussions around how pharma and software companies can work together to generate success on both sides.
Addressing challenges
What are some challenges in drug discovery? Why do we need AI and ML-driven solutions in the first place?
Collaboration
With technologies such as ChatGPT pictured as futuristic, how can collaboration between tech and the already existing human force be leveraged to yield success?
Data
What are some solutions/strategies should pharmaceutical companies consider for better management of data in hand?
World-Class Business Leaders and Speakers
Why Attend?

Understand
The big picture, not just the individual strands of the business you work in

Connect
And build relationships with some of the biggest names in your industry

Discover
New approaches and strategies to help win market share
Join Us On 25 April
FT Live Digital Dialogues - fully digital one hour event experiences delivering maximum engagement. Live webinars provide unique opportunities to engage global senior audiences. All access, digital passes include access to all the live sessions PLUS all sessions on demand for 30 days. Join the conversation.
We’re Here To Help
© Financial Times Live
FT Live and its journalism are subject to a self-regulation regime under the FT Editorial Code of Practice